Skip to main content
Clinical Trials/IRCT20200324046850N3
IRCT20200324046850N3
Completed
Phase 3

The effect of naproxen on the healing process of patients with COVID-19

Abadan University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 3
Status
Completed
Sponsor
Abadan University of Medical Sciences
Enrollment
80

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to no limit (—)
Sex
All

Inclusion Criteria

  • COVID\-19 patients that have positive PCR test of nasopharyngeal sample or have positive CT Scan
  • Having consent to participate in the intervention

Exclusion Criteria

  • pregnant or breast feeding women
  • Those taking losartan and captopril.
  • Those with a history of intestinal ulcers or gastrointestinal bleeding.
  • Children under 14 years

Investigators

Sponsor
Abadan University of Medical Sciences

Similar Trials